BMC Systems Biology

BackgroundThe TGF-β/SMAD pathway is part of a broader signaling network in which crosstalk between pathways occurs. While the molecular mechanisms of TGF-β/SMAD signaling pathway have been studied in detail, the global networks downstream of SMAD remain largely unknown. The regulatory effect of SMAD complex likely depends on transcriptional modules, in which the SMAD binding elements and partner transcription factor binding sites (SMAD modules) are present in specific context.ResultsTo address this question and develop a computational model for SMAD modules, we simultaneously performed chromatin immunoprecipitation followed by microarray analysis (ChIP-chip) and mRNA expression profiling to identify TGF-β/SMAD regulated and synchronously coexpressed gene sets in ovarian surface epithelium. Intersecting the ChIP-chip and gene expression data yielded 150 direct targets, of which 141 were grouped into 3 co-expressed gene sets (sustained up-regulated, transient up-regulated and down-regulated), based on their temporal changes in expression after TGF-β activation. We developed a data-mining method driven by the Random Forest algorithm to model SMAD transcriptional modules in the target sequences. The predicted SMAD modules contain SMAD binding element and up to 2 of 7 other transcription factor binding sites (E2F, P53, LEF1, ELK1, COUPTF, PAX4 and DR1).ConclusionTogether, the computational results further the understanding of the interactions between SMAD and other transcription factors at specific target promoters, and provide the basis for more targeted experimental verification of the co-regulatory modules.

[1]  H. Parviainen,et al.  GATA-4 is a granulosa cell factor employed in inhibin-alpha activation by the TGF-beta pathway. , 2006, Journal of molecular endocrinology.

[2]  P. Mellon,et al.  Activin regulation of the follicle-stimulating hormone beta-subunit gene involves Smads and the TALE homeodomain proteins Pbx1 and Prep1. , 2004, Molecular endocrinology.

[3]  J. Massagué,et al.  Transcriptional control by the TGF‐β/Smad signaling system , 2000 .

[4]  Dongsun Cao,et al.  Bone Morphogenetic Protein Signaling Modulates Myocardin Transactivation of Cardiac Genes , 2005, Circulation research.

[5]  Roger R. Gomis,et al.  C/EBPβ at the core of the TGFβ cytostatic response and its evasion in metastatic breast cancer cells , 2006 .

[6]  John J. Wyrick,et al.  Genome-wide location and function of DNA binding proteins. , 2000, Science.

[7]  Huaxia Qin,et al.  Aberrant transforming growth factor beta1 signaling and SMAD4 nuclear translocation confer epigenetic repression of ADAM19 in ovarian cancer. , 2008, Neoplasia.

[8]  R. Derynck,et al.  TGF-β signaling in cancer – a double-edged sword , 2001 .

[9]  Curt Balch,et al.  Identification and characterization of ovarian cancer-initiating cells from primary human tumors. , 2008, Cancer research.

[10]  J. Massagué,et al.  C/EBPbeta at the core of the TGFbeta cytostatic response and its evasion in metastatic breast cancer cells. , 2006, Cancer cell.

[11]  Andrew Leask,et al.  The induction of CCN2 by TGFβ1 involves Ets-1 , 2006, Arthritis research & therapy.

[12]  Michael S. German,et al.  Paired-Homeodomain Transcription Factor PAX4 Acts as a Transcriptional Repressor in Early Pancreatic Development , 1999, Molecular and Cellular Biology.

[13]  Megan F. Cole,et al.  Control of Developmental Regulators by Polycomb in Human Embryonic Stem Cells , 2006, Cell.

[14]  P. Santisteban,et al.  The Functional Interaction between the Paired Domain Transcription Factor Pax8 and Smad3 Is Involved in Transforming Growth Factor-β Repression of the Sodium/Iodide Symporter Gene* , 2004, Journal of Biological Chemistry.

[15]  J. Massagué,et al.  Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus , 2003, Cell.

[16]  Tim Hui-Ming Huang,et al.  MPromDb: an integrated resource for annotation and visualization of mammalian gene promoters and ChIP-chip experimental data , 2005, Nucleic Acids Res..

[17]  Santiago Lamas,et al.  Functional Cooperation Between Smad Proteins and Activator Protein-1 Regulates Transforming Growth Factor-&bgr;–Mediated Induction of Endothelin-1 Expression , 2003, Circulation research.

[18]  Terje Johansen,et al.  The MH1 domain of Smad3 interacts with Pax6 and represses autoregulation of the Pax6 P1 promoter , 2007, Nucleic acids research.

[19]  K. Lunetta,et al.  Identifying SNPs predictive of phenotype using random forests , 2005, Genetic epidemiology.

[20]  Todd Evans,et al.  An Oct-1 binding site mediates activation of the gata2 promoter by BMP signaling , 2005, Nucleic acids research.

[21]  L. Attisano,et al.  Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Christian Sirard,et al.  Smad4 and β-Catenin Co-activators Functionally Interact with Lymphoid-enhancing Factor to Regulate Graded Expression of Msx2* , 2003, Journal of Biological Chemistry.

[23]  Wei He,et al.  A FoxO–Smad synexpression group in human keratinocytes , 2006, Proceedings of the National Academy of Sciences.

[24]  S. Dudoit,et al.  Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. , 2002, Nucleic acids research.

[25]  Megan F. Cole,et al.  Core Transcriptional Regulatory Circuitry in Human Embryonic Stem Cells , 2005, Cell.

[26]  Kyucheol Cho,et al.  Transforming growth factor-β1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-κB, JNK, and Ras signaling pathways , 2003, Oncogene.

[27]  Ken Yagi,et al.  c-myc Is a Downstream Target of the Smad Pathway* 210 , 2002, The Journal of Biological Chemistry.

[28]  Mark Hurle,et al.  Revealing transforming growth factor-beta signaling transduction in human kidney by gene expression data mining. , 2005, Omics : a journal of integrative biology.

[29]  E. Wingender,et al.  MATCH: A tool for searching transcription factor binding sites in DNA sequences. , 2003, Nucleic acids research.

[30]  J. Massagué,et al.  Mechanisms of TGF-beta signaling from cell membrane to the nucleus. , 2003, Cell.

[31]  Denis Vivien,et al.  Direct binding of Smad3 and Smad4 to critical TGFβ‐inducible elements in the promoter of human plasminogen activator inhibitor‐type 1 gene , 1998, The EMBO journal.

[32]  Shi Lei,et al.  Synergistic activation of the murine gastrin promoter by oncogenic Ras and beta-catenin involves SMAD recruitment. , 2005, Biochemical and biophysical research communications.

[33]  Michael Q. Zhang,et al.  Mining ChIP-chip data for transcription factor and cofactor binding sites , 2005, ISMB.

[34]  Robert Walgate,et al.  Proliferation , 1985, Nature.

[35]  Alexander E. Kel,et al.  MATCHTM: a tool for searching transcription factor binding sites in DNA sequences , 2003, Nucleic Acids Res..

[36]  J. Massagué,et al.  Smad transcription factors. , 2005, Genes & development.

[37]  A. Moustakas,et al.  Mechanism of a transcriptional cross talk between transforming growth factor-beta-regulated Smad3 and Smad4 proteins and orphan nuclear receptor hepatocyte nuclear factor-4. , 2003, Molecular biology of the cell.

[38]  D. Berger,et al.  Cooperation between GATA4 and TGF-beta signaling regulates intestinal epithelial gene expression. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[39]  T. Shioda,et al.  The Smad4 Activation Domain (SAD) Is a Proline-rich, p300-dependent Transcriptional Activation Domain* , 2000, The Journal of Biological Chemistry.

[40]  Sandya Liyanarachchi,et al.  Combinatorial analysis of transcription factor partners reveals recruitment of c-MYC to estrogen receptor-alpha responsive promoters. , 2006, Molecular cell.

[41]  Fang Liu,et al.  Activation of Smad transcriptional activity by protein inhibitor of activated STAT3 (PIAS3) , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[42]  S. Anderson,et al.  Integration of Smad and Forkhead Pathways in the Control of Neuroepithelial and Glioblastoma Cell Proliferation , 2004, Cell.

[43]  Jian Wang,et al.  Dickkopf-1, an inhibitor of the Wnt signaling pathway, is induced by p53 , 2000, Oncogene.

[44]  Kunihiro Tsuchida,et al.  Transcriptional Activation of Mouse Mast Cell Protease-7 by Activin and Transforming Growth Factor-β Is Inhibited by Microphthalmia-associated Transcription Factor* , 2003, Journal of Biological Chemistry.

[45]  Neil D. Lawrence,et al.  A Comparison of State-of-the-Art Classification Techniques with Application to Cytogenetics , 2001, Neural Computing & Applications.

[46]  R. Derynck,et al.  TGF-beta signaling in cancer--a double-edged sword. , 2001, Trends in cell biology.

[47]  R. Tjian,et al.  Diversified transcription initiation complexes expand promoter selectivity and tissue-specific gene expression. , 2003, Genes & development.

[48]  J. Massagué,et al.  Opposite Smad and Chicken Ovalbumin Upstream Promoter Transcription Factor Inputs in the Regulation of the Collagen VII Gene Promoter by Transforming Growth Factor-β* , 2004, Journal of Biological Chemistry.

[49]  Steven Gallinger,et al.  Transcriptional cooperation between the transforming growth factor-beta and Wnt pathways in mammary and intestinal tumorigenesis. , 2007, Cancer research.

[50]  Ying Cao,et al.  The POU Factor Oct-25 Regulates the Xvent-2B Gene and Counteracts Terminal Differentiation in Xenopus Embryos* , 2004, Journal of Biological Chemistry.

[51]  Jouni Uitto,et al.  Transcriptional control of the mouse Col7a1 gene in keratinocytes: basal and transforming growth factor-beta regulated expression. , 2003, The Journal of investigative dermatology.

[52]  Hiroshi Furukawa,et al.  PAX4 has the potential to function as a tumor suppressor in human melanoma. , 2008, International journal of oncology.

[53]  Leo Breiman,et al.  Random Forests , 2001, Machine Learning.

[54]  Clifford A. Meyer,et al.  Genome-wide analysis of estrogen receptor binding sites , 2006, Nature Genetics.

[55]  M. L. Howard,et al.  cis-Regulatory control circuits in development. , 2004, Developmental biology.

[56]  Marc S. Halfon,et al.  Prediction of similarly acting cis-regulatory modules by subsequence profiling and comparative genomics in Drosophila melanogaster and D.pseudoobscura , 2004, Bioinform..

[57]  Stefano Piccolo,et al.  Integration of TGF-ß and Ras/MAPK Signaling Through p53 Phosphorylation , 2007, Science.

[58]  Leo Breiman,et al.  Classification and Regression Trees , 1984 .

[59]  Marc Tessier-Lavigne,et al.  The Hedgehog, TGF-beta/BMP and Wnt families of morphogens in axon guidance. , 2007, Advances in experimental medicine and biology.

[60]  J. Williams,et al.  STAT signalling in cell proliferation and in development. , 2000, Current opinion in genetics & development.

[61]  N. Wake,et al.  Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer. , 2000, Cancer research.

[62]  T. Gelehrter,et al.  Smad4/DPC4 and Smad3 Mediate Transforming Growth Factor-β (TGF-β) Signaling through Direct Binding to a Novel TGF-β-responsive Element in the Human Plasminogen Activator Inhibitor-1 Promoter* , 1998, The Journal of Biological Chemistry.

[63]  David S Alberts,et al.  Expression and mutational analysis of tyrosine kinase receptors c-kit, PDGFRalpha, and PDGFRbeta in ovarian cancers. , 2005, Human pathology.

[64]  Murray Korc,et al.  Smad7 Abrogates Transforming Growth Factor-β1-mediated Growth Inhibition in COLO-357 Cells through Functional Inactivation of the Retinoblastoma Protein* , 2005, Journal of Biological Chemistry.

[65]  Stephen B. Howell,et al.  Expression and mutational analysis of tyrosine kinase receptors c-kit, PDGFRalpha, and PDGFRbeta in ovarian cancers. , 2005, Human pathology.

[66]  J. Winderickx,et al.  Inferring transcriptional modules from ChIP-chip, motif and microarray data , 2006, Genome Biology.

[67]  A. Okamoto,et al.  Allelic imbalance in chromosome band 18q21 and SMAD4 mutations in ovarian cancers , 1999, Genes, chromosomes & cancer.

[68]  M. Barton,et al.  A Direct Intersection between p53 and Transforming Growth Factor β Pathways Targets Chromatin Modification and Transcription Repression of the α-Fetoprotein Gene , 2005, Molecular and Cellular Biology.

[69]  Takayuki Furumatsu,et al.  Smad3 Induces Chondrogenesis through the Activation of SOX9 via CREB-binding Protein/p300 Recruitment*[boxs] , 2005, Journal of Biological Chemistry.

[70]  Mikko Anttonen,et al.  GATA-4 is a granulosa cell factor employed in inhibin-α activation by the TGF-β pathway , 2006 .

[71]  Yudong D. He,et al.  Functional Discovery via a Compendium of Expression Profiles , 2000, Cell.

[72]  J. Massagué,et al.  E2F4/5 and p107 as Smad Cofactors Linking the TGFβ Receptor to c-myc Repression , 2002, Cell.

[73]  R. W. Padgett,et al.  Genome-wide microarray analysis of TGFβ signaling in the Drosophila brain , 2004, BMC Developmental Biology.

[74]  Beth Y Karlan,et al.  Loss of c-myc repression coincides with ovarian cancer resistance to transforming growth factor beta growth arrest independent of transforming growth factor beta/Smad signaling. , 2003, Cancer research.

[75]  M. Skinner,et al.  Autocrine interactions of keratinocyte growth factor, hepatocyte growth factor, and kit-ligand in the regulation of normal ovarian surface epithelial cells. , 2000, Endocrinology.

[76]  A. Grinberg,et al.  Both Max and TFE3 Cooperate with Smad Proteins to Bind the Plasminogen Activator Inhibitor-1 Promoter, but They Have Opposite Effects on Transcriptional Activity* 210 , 2003, The Journal of Biological Chemistry.

[77]  Anping Chen,et al.  Disruption of transforming growth factor-beta signaling by curcumin induces gene expression of peroxisome proliferator-activated receptor-gamma in rat hepatic stellate cells. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[78]  Liliana Attisano,et al.  Synergistic Cooperation between Hypoxia and Transforming Growth Factor-β Pathways on Human Vascular Endothelial Growth Factor Gene Expression* , 2001, The Journal of Biological Chemistry.

[79]  Robert Gentleman,et al.  R Programming for Bioinformatics , 2008 .

[80]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[81]  M. Barton,et al.  A direct intersection between p53 and transforming growth factor beta pathways targets chromatin modification and transcription repression of the alpha-fetoprotein gene. , 2005, Molecular and cellular biology.

[82]  F. Hoffmann,et al.  Smad4 cooperates with lymphoid enhancer-binding factor 1/T cell-specific factor to increase c-myc expression in the absence of TGF-β signaling , 2006, Proceedings of the National Academy of Sciences.

[83]  Peter Scheurich,et al.  p53 upregulates cFLIP, inhibits transcription of NF-κB-regulated genes and induces caspase-8-independent cell death in DLD-1 cells , 2001, Oncogene.

[84]  Anping Chen,et al.  Disruption of transforming growth factor-β signaling by curcumin induces gene expression of peroxisome proliferator-activated receptor-γ in rat hepatic stellate cells , 2007 .

[85]  Stefano Piccolo,et al.  Integration of TGF-beta and Ras/MAPK signaling through p53 phosphorylation. , 2007, Science.

[86]  A. Balmain,et al.  TGF-beta signaling in tumor suppression and cancer progression. , 2001, Nature genetics.

[87]  Adele Cutler,et al.  Random forests for microarrays. , 2006, Methods in enzymology.

[88]  Malte Buchholz,et al.  Sp1 is required for transforming growth factor-beta-induced mesenchymal transition and migration in pancreatic cancer cells. , 2007, Cancer research.

[89]  F. Verrecchia,et al.  Retinoic acid receptors interfere with the TGF-β/Smad signaling pathway in a ligand-specific manner , 2003, Oncogene.

[90]  Barbara C Vanderhyden,et al.  Transforming growth factor-β regulates Kit ligand expression in rat ovarian surface epithelial cells , 1999, Oncogene.

[91]  J. Foley,et al.  Parathyroid hormone-related protein gene expression in human squamous carcinoma cells is repressed by mutant isoforms of p53. , 1996, Cancer research.

[92]  R. Bast,et al.  Regulation of growth of normal ovarian epithelial cells and ovarian cancer cell lines by transforming growth factor-beta. , 1992, American journal of obstetrics and gynecology.

[93]  R. L. Baldwin,et al.  Ovarian carcinoma cell cultures are resistant to TGF-beta1-mediated growth inhibition despite expression of functional receptors. , 1999, Gynecologic oncology.

[94]  K. Miyazono,et al.  Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300. , 1999, Science.

[95]  Hongyu Zhao,et al.  Pathway analysis using random forests classification and regression , 2006, Bioinform..

[96]  R S Ismail,et al.  Transforming growth factor-beta regulates Kit ligand expression in rat ovarian surface epithelial cells. , 1999, Oncogene.

[97]  R. Derynck,et al.  SPECIFICITY AND VERSATILITY IN TGF-β SIGNALING THROUGH SMADS , 2005 .

[98]  F. Robert,et al.  Genome-wide computational prediction of transcriptional regulatory modules reveals new insights into human gene expression , 2006 .

[99]  S. Mok,et al.  Expression profiling identifies altered expression of genes that contribute to the inhibition of transforming growth factor-beta signaling in ovarian cancer. , 2006, Cancer research.

[100]  K. Lunetta,et al.  Screening large-scale association study data: exploiting interactions using random forests , 2004, BMC Genetics.

[101]  R. Derynck,et al.  Specificity and versatility in tgf-beta signaling through Smads. , 2005, Annual review of cell and developmental biology.

[102]  Anthony A. Philippakis,et al.  Expression-Guided In Silico Evaluation of Candidate Cis Regulatory Codes for Drosophila Muscle Founder Cells , 2006, PLoS Comput. Biol..

[103]  T. Speed,et al.  Summaries of Affymetrix GeneChip probe level data. , 2003, Nucleic acids research.

[104]  Chris Sander,et al.  Signal Processing in the TGF-β Superfamily Ligand-Receptor Network , 2005, PLoS Comput. Biol..

[105]  S. Yamashita,et al.  Dexamethasone inhibition of TGF beta-induced cell growth and type II collagen mRNA expression through ERK-integrated AP-1 activity in cultured rat articular chondrocytes. , 2000, Osteoarthritis and cartilage.

[106]  Xiao-Fan Wang,et al.  Functional Analysis of the Transforming Growth Factor βResponsive Elements in the WAF1/Cip1/p21 Promoter (*) , 1995, The Journal of Biological Chemistry.

[107]  Dipak P. Ramji,et al.  A critical role for the Sp1-binding sites in the transforming growth factor-β-mediated inhibition of lipoprotein lipase gene expression in macrophages , 2005, Nucleic acids research.